Safety, Tolerability of JMKX003002 in Phase 1 Study in Healthy Subjects

Updated 05/03/2024

Status Recruiting

Clinical Trial Summary

Safety, tolerability, pharmacokinetics, and pharmacodynamics of JMKX003002 in single and multiple ascending dose randomized，doubled-blind phase 1 study in healthy subjects

Clinical Trial Description

Pharmacokinetic (PK) parameters, Pharmacodynamics ;

Study Design

Related Conditions & MeSH terms

Safety and Tolerability

Clinical Trial Details

NCT number	NCT05907382
Study type	Interventional
Source	Jemincare
Contact	Jing Xu
Phone	021-52887926
Email	xujing2@jimincare.com
Status	Recruiting
Phase	Phase 1
Start date	May 9, 2023
Completion date	March 2024

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06000891` - A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570	Phase 1
	Active, not recruiting	`NCT05997641` - Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects	Phase 1
	Completed	`NCT06181760` - A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers	Phase 1
	Completed	`NCT01952548` - Study Comparing the Pharmacokinetics, Pharmacodynamics, and Safety of K-312 in Healthy Adult Volunteers	Phase 1
	Completed	`NCT05431634` - Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants	Phase 1
	Recruiting	`NCT06331884` - Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)	Phase 1
	Completed	`NCT03046589` - DP13 SAD & MAD in Healthy Male Subjects	Phase 1
	Recruiting	`NCT06079541` - Phase 1 Clinical Study of JMKX003142 Tablets	Phase 1
	Completed	`NCT05223660` - A Phase I Pharmacokinetics Study for KT07 Capsule	Phase 1
	Completed	`NCT01907867` - Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin	Phase 1
	Completed	`NCT03809052` - A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects	Phase 1
	Completed	`NCT03853421` - Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin	Phase 1
	Terminated	`NCT03307512` - PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD	Phase 2
	Completed	`NCT03702231` - Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)	Phase 2
	Completed	`NCT03685708` - HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)	Phase 2
	Completed	`NCT03817346` - Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers	Phase 1
	Active, not recruiting	`NCT01226316` - Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules	Phase 1
	Completed	`NCT05451667` - Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers	Phase 1
	Completed	`NCT02029482` - Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-128800 in Healthy Subjects	Phase 1